Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Inhibiting HSP90 to treat cancer: a strategy in evolution.

Inhibiting HSP90 to treat cancer: a strategy in evolution. Curr Mol Med. 2012 Nov 01; 12(9):1108-24.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.